RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
New Haven, CT · +49 more sites
4 recruiting ulcerative colitis studies with a site in New Haven, CT.
Sponsor: National Cancer Institute (NCI)
New Haven, CT · +49 more sites
Sponsor: Sanofi
New Haven, CT · +117 more sites
Sponsor: Mayo Clinic
New Haven, CT · +23 more sites
Sponsor: University of North Carolina, Chapel Hill
New Haven, CT · +10 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.